$264 | SAVE $36 | Single User
$528 | SAVE $72 | Site License
$792 | SAVE $108 | Enterprise License

Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review
[Published by Global Data]

Published by Global Data: 11 Jul 2016 | 14382 | In Stock

Introduction

Summary

Korea United Pharm, Inc. (KUP) is a pharmaceutical company that offers health foods. The company produces, markets, sells and distributes pharmaceutical and other healthcare products. It operates through three business segments namely, active pharmaceutical ingredients, pharmaceuticals and health foods. KUP offers a wide range of pharmaceuticals including alphacolin, tefudex ca, newbutin s, superset t and nevicure t. The company’s API products include talniflumate, simvastatin, paroxetine and carvedilol. Its health foods include joy support, green-c, coral-d, 3g and nonial-s. The company provides products to gastrointestinal, cardiovascular and hematopoietic, respiratory, central nervous system, musculo-skeletal, endocrine and metabolic; and others. KUP is headquartered in Kangnam-ku, South Korea.

This comprehensive SWOT profile of Korea United Pharm, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Korea United Pharm, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

  • Table of Contents

    Section 1 - About the Company

    Korea United Pharm, Inc. - Key Information

    Korea United Pharm, Inc. - Overview

    Korea United Pharm, Inc. - Key Employees

    Korea United Pharm, Inc. - Key Employee Biographies

    Korea United Pharm, Inc. - Key Operational Heads

    Korea United Pharm, Inc. - Major Products and Services

    Korea United Pharm, Inc. - History

    Korea United Pharm, Inc. - Company Statement

    Korea United Pharm, Inc. - Locations And Subsidiaries

    Korea United Pharm, Inc. - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Korea United Pharm, Inc. - Business Description

    Korea United Pharm, Inc. - Corporate Strategy

    Korea United Pharm, Inc. - SWOT Analysis

    SWOT Analysis - Overview

    Korea United Pharm, Inc. - Strengths

    Korea United Pharm, Inc. - Weaknesses

    Korea United Pharm, Inc. - Opportunities

    Korea United Pharm, Inc. - Threats

    Korea United Pharm, Inc. - Key Competitors

    Section 3 - Company Financial Performance Charts

    Korea United Pharm, Inc. - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Tables


Korea United Pharm, Inc., Key Information

Korea United Pharm, Inc., Key Ratios

Korea United Pharm, Inc., Share Data

Korea United Pharm, Inc., Major Products and Services

Korea United Pharm, Inc., History

Korea United Pharm, Inc., Key Employees

Korea United Pharm, Inc., Key Employee Biographies

Korea United Pharm, Inc., Key Operational Heads

Korea United Pharm, Inc., Other Locations

Korea United Pharm, Inc., Subsidiaries

Korea United Pharm, Inc., Key Manufacturing facilities

Korea United Pharm, Inc., Key Competitors

Korea United Pharm, Inc., SWOT Analysis

Korea United Pharm, Inc., Ratios based on current share price

Korea United Pharm, Inc., Annual Ratios

Korea United Pharm, Inc., Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review [Published by Global Data]

List of Figures


Korea United Pharm, Inc., Performance Chart

Korea United Pharm, Inc., Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

14382 | GDPH81998FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Sanofi-Aventis Korea Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySanofi-Aventis Korea Co., Ltd. (Sanofi-Aventis) a subsidiary of Sanofi is a pharmaceutical co...
10 May 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Korea Research Institute of Chemical Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryKorea Research Institute of Chemical Technology (KRICT) is a chemical technology institute th...
27 Apr 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Alvogen Korea Co., Ltd. (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
15 Apr 2016 by Global Data USD $264 (normally
USD $300)
More Info
SAVE 12% today! Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review
SummaryKorea United Pharm, Inc. (KUP) is a pharmaceutical company that offers health foods. The comp...
15 Apr 2016 by Global Data USD $264 (normally
USD $300)
More Info
SAVE 12% today! Korea Research Institute of Chemical Technology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryKorea Research Institute of Chemical Technology (KRICT) is a chemical technology institute th...
18 Mar 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Sanofi-Aventis Korea Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummarySanofi-Aventis Korea Co., Ltd. (Sanofi-Aventis) a subsidiary of Sanofi is a pharmaceutical co...
16 Mar 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Alvogen Korea (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
09 Jan 2016 by Global Data USD $264 (normally
USD $300)
More Info
SAVE 12% today! Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review
SummaryKorea United Pharm, Inc. (KUP) is a pharmaceutical company that offers health foods. The comp...
09 Jan 2016 by Global Data USD $264 (normally
USD $300)
More Info
SAVE 12% today! Alvogen Korea (002250) - Financial and Strategic SWOT Analysis Review
SummaryAlvogen Korea (Alvogen) formerly KunWha Pharmaceutical Co., Ltd., a subsidiary of Alvogen, In...
08 Nov 2015 by Global Data USD $264 (normally
USD $300)
More Info
SAVE 12% today! Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review
SummaryKorea United Pharm, Inc. (KUP) is a pharmaceutical company that offers health foods. The comp...
08 Nov 2015 by Global Data USD $264 (normally
USD $300)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...